Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.6 - $1.5 $1,175 - $2,938
-1,959 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.44 - $5.22 $565 - $2,051
393 Added 25.1%
1,959 $3,000
Q4 2021

Feb 15, 2022

SELL
$4.7 - $15.0 $4,530 - $14,460
-964 Reduced 38.1%
1,566 $8,000
Q3 2021

Nov 15, 2021

SELL
$9.77 - $15.77 $62,830 - $101,416
-6,431 Reduced 71.77%
2,530 $37,000
Q2 2021

Aug 16, 2021

SELL
$9.26 - $12.53 $5,157 - $6,979
-557 Reduced 5.85%
8,961 $103,000
Q1 2021

May 18, 2021

BUY
$9.47 - $16.26 $90,135 - $154,762
9,518 New
9,518 $92,000

About Landos Biopharma, Inc.


  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.